BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2677918)

  • 1. Expression of int-2 mRNA in human tumors amplified at the int-2 locus.
    Liscia DS; Merlo GR; Garrett C; French D; Mariani-Costantini R; Callahan R
    Oncogene; 1989 Oct; 4(10):1219-24. PubMed ID: 2677918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of the int-2 gene in primary human breast tumors.
    Lidereau R; Callahan R; Dickson C; Peters G; Escot C; Ali IU
    Oncogene Res; 1988 Feb; 2(3):285-91. PubMed ID: 2835739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
    Ali IU; Merlo G; Callahan R; Lidereau R
    Oncogene; 1989 Jan; 4(1):89-92. PubMed ID: 2915903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT and FGF gene clusters (review).
    Katoh M
    Int J Oncol; 2002 Dec; 21(6):1269-73. PubMed ID: 12429977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma.
    Adelaide J; Mattei MG; Marics I; Raybaud F; Planche J; De Lapeyriere O; Birnbaum D
    Oncogene; 1988 Apr; 2(4):413-6. PubMed ID: 3283658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
    Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
    Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and expression of the bcl-1 gene in human solid tumor cell lines.
    Faust JB; Meeker TC
    Cancer Res; 1992 May; 52(9):2460-3. PubMed ID: 1568216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL-1 participates in the 11q13 amplification found in breast cancer.
    Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
    Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
    Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
    Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH
    Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors.
    Roelink H; Wagenaar E; Nusse R
    Oncogene; 1992 Mar; 7(3):487-92. PubMed ID: 1549363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
    Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
    Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors.
    Strohmeyer T; Peter S; Hartmann M; Munemitsu S; Ackermann R; Ullrich A; Slamon DJ
    Cancer Res; 1991 Apr; 51(7):1811-6. PubMed ID: 1706218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas.
    Theillet C; Le Roy X; De Lapeyrière O; Grosgeorges J; Adnane J; Raynaud SD; Simony-Lafontaine J; Goldfarb M; Escot C; Birnbaum D
    Oncogene; 1989 Jul; 4(7):915-22. PubMed ID: 2474139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
    Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
    Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
    Clausse N; Baines D; Moore R; Brookes S; Dickson C; Peters G
    Virology; 1993 May; 194(1):157-65. PubMed ID: 8386870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.